Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03639324 |
| Title | Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL (RIVe-CLL) |
| Acronym | RIVe-CLL/SLL |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Virginia Commonwealth University |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|